Radiation Therapy Damages Neurons

Cranial irradiation, a common brain cancer treatment, disrupts neural morphology in mice in ways that resemble damage caused by neurodegenerative conditions.

Written byChris Palmer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, RAMACranial radiation therapy, or radiation targeted to the brain, has been an effective means of decreasing the size of brain tumors. However, the treatment is known to cause neurological dysfunction later in life, though the exact mechanisms underlying the damage have not been clear. Research published Monday (July 15) in the Proceedings of the National Academy of Sciences, demonstrates that the life-saving therapy compromises the structure of neurons in mice.

Vipan Parihar and Charles Limoli, oncologists at the University of California, Irvine, observed a significant reduction in the complexity of dendrites—the branch-like structures on neurons that receive input from other neurons—following treatment with a low dose of radiation—equivalent to a dose used for children—or a dose 10 times higher. Dendritic branching, as well as dendritic length and area, were reduced by more than 50 percent for both doses.

The radiation therapy resulted in a 20 to 35 percent reduction in the number of neurons in the hippocampus and a 40 to 70 percent reduction in the density of dendritic spines—knob-like structures that make synaptic connections with axons of other neurons. Immature dendritic proto-spines were reduced in number 40 percent 10 days after the high dose. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies